Destiny Pharma (LSE:DEST) Other Current Liabilities : £0.30 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma Other Current Liabilities?

Destiny Pharma's other current liabilities for the quarter that ended in Dec. 2023 was £0.30 Mil.

Destiny Pharma's quarterly other current liabilities declined from Dec. 2022 (£0.92 Mil) to Jun. 2023 (£0.00 Mil) but then increased from Jun. 2023 (£0.00 Mil) to Dec. 2023 (£0.30 Mil).

Destiny Pharma's annual other current liabilities increased from Dec. 2021 (£0.47 Mil) to Dec. 2022 (£0.92 Mil) but then declined from Dec. 2022 (£0.92 Mil) to Dec. 2023 (£0.30 Mil).

Destiny Pharma Other Current Liabilities Historical Data

The historical data trend for Destiny Pharma's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Destiny Pharma Other Current Liabilities Chart

Destiny Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Destiny Pharma Semi-Annual Data
	Dec14	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial												-	-	-	-	-

Destiny Pharma Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Destiny Pharma Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Destiny Pharma (LSE:DEST) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

D89:Germany

Address

Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB

Website

https://www.destinypharma.com

Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines